Table. 1.

Patient characteristics

Variable Reoperation group (n=98) Non-reoperation group (n=407) P-value
Preoperative
Age (yr) 52.7±8.1 53.7±8.7 0.335
Male sex 74 (75.5) 325 (80.0) 0.367
BMI (kg/m2) 24.3±3.9 24.7±3.55 0.377
Indication for transplantation 0.154
HCC 58 (59.2) 259 (63.5)
Viral hepatitis 15 (15.3) 83 (20.4)
Alcoholic 13 (13.3) 26 (6.4)
AIH 2 (2.0) 6 (1.5)
Others 10 (10.2) 34 (8.3)
Hepatic encephalopathy with grade 3–4 3 (3.1) 19 (4.7) 0.059
Varix bleeding 10 (10.2) 47 (11.5) 0.711
Uncontrolled ascites 15 (15.3) 56 (13.8) 0.225
Hepatorenal syndrome with CRRT 4 (4.1) 9 (2.2) 0.074
Spontaneous bacterial peritonitis 4 (4.1) 10 (2.5) 0.377
Ventilatory care before transplantation 0 10 (2.5) 0.117
Child-Pugh classification 0.734
A 34 (34.7) 159 (39.1)
B 34 (34.7) 131 (32.2)
C 30 (30.6) 118 (29.0)
MELD score 15.6±9.3 16.0±10.3 0.690
GRWR 1.11±0.2 1.09±0.3 0.364
GV/SLV 58.8±11.2 59.9±27.5 0.698
Previous abdominal operation history 22 (22.4) 68 (16.7) 0.179
Previous HCC-related operation history 17 (17.3) 39 (9.6) 0.027
Perioperative
CIT (min) 89.5±33.3 59.9±31.2 0.917
WIT (min) 36.3±25.6 36.2±13.3 0.959
Operation time (min) 591.6±121.0 553.1±104.1 0.002
Intraoperative transfusion (unit)
RBC 3.0±6.6 2.0±3.8 0.166
FFP 2.9±6.1 2.1±3.6 0.228
SDP 1.1±4.1 0.9 (2.8) 0.595
Cryoprecipitate 3.4±6.5 2.6±4.2 0.153
Hospitalization (day) 45.5±48.5 35.3±29.1 0.049
Postoperative ICU stay (day) 7.7±3.2 7.2±7.1 0.526

Values are presented as mean±standard deviation or number (%).

BMI, body mass index; HCC, hepatocellular carcinoma; AIH, autoimmune hepatitis; CRRT, continuous renal replacement therapy; MELD, model for end-stage liver disease; GRWR, graft-to-recipient body weight ratio; GV, graft volume; SLV, standard liver volume; CIT, cold ischemic time; WIT, warm ischemic time; RBC, red blood cell; FFP, fresh frozen plasma; SDP, single donor platelet; ICU, intensive care unit.

Korean J Transplant 2019;33:128~134 https://doi.org/10.4285/jkstn.2019.33.4.128
© Korean Journal of Transplantation